Ligand Pharmaceuticals LGND
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 189.07 | 1,017 | 4.55 | 45 | 2.95 | 1,561 |
| 2025Q3 | 177.14 | 950 | 13.19 | 117 | 9.67 | 1,477 |
| 2025Q2 | 113.68 | 829 | 0.60 | 5 | 0.52 | 949 |
| 2025Q1 | 105.14 | 796 | -5.22 | -42 | -4.60 | 905 |
| 2024Q4 | 107.15 | 830 | -3.72 | -31 | -3.28 | 942 |
| 2024Q3 | 100.09 | 841 | -0.89 | -7 | -0.79 | 955 |
| 2024Q2 | 84.26 | 775 | -6.56 | -52 | -5.83 | 866 |
| 2024Q1 | 73.10 | 807 | 11.43 | 86 | 10.13 | 914 |
| 2023Q4 | 71.42 | 701 | 2.66 | 18 | 2.34 | 787 |
| 2023Q3 | 59.92 | 668 | -1.54 | -10 | -1.35 | 769 |
| 2023Q2 | 72.10 | 665 | 0.35 | 2 | 0.29 | 758 |
| 2023Q1 | 73.56 | 646 | 6.75 | 42 | 5.33 | 811 |
| 2022Q4 | 66.80 | 597 | -2.47 | -17 | -1.93 | 763 |
| 2022Q3 | 86.11 | 816 | 0.05 | 0 | 0.04 | 1,051 |
| 2022Q2 | 89.22 | 802 | -0.11 | -1 | -0.08 | 1,076 |
| 2022Q1 | 112.49 | 793 | -1.91 | -15 | -1.28 | 1,105 |
| 2021Q4 | 154.46 | 821 | -0.66 | -5 | -0.42 | 1,298 |
| 2021Q3 | 139.32 | 812 | 1.72 | 14 | 1.08 | 1,274 |
| 2021Q2 | 131.19 | 787 | 4.01 | 31 | 2.41 | 1,256 |
| 2021Q1 | 152.45 | 746 | 2.49 | 18 | 1.36 | 1,295 |